Chemotherapy (unspecified)
Drug timelines are a Plus or Pro feature.
30 regulatory and trial events tracked for Chemotherapy (unspecified), covering 2010-09-17 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer [Phase 1, Phase 2]